Education
About Us
Working with TipRanks
Follow Us
Waverley Pharma (TSE:WAVE)
:WAVE
WAVE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.04
Previous CloseN/A
VolumeN/A
Average Volume (3M)633.00
Market Cap
C$1.08M
Enterprise ValueC$3.55M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Apr 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding54,000,000
10 Day Avg. Volume500
30 Day Avg. Volume633
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Waverley Pharma News
WAVE FAQ
What was Waverley Pharma’s price range in the past 12 months?
Waverley Pharma lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Waverley Pharma’s market cap?
Waverley Pharma’s market cap is C$1.08M.
When is Waverley Pharma’s upcoming earnings report date?
Waverley Pharma’s upcoming earnings report date is Apr 23, 2026 which is in 205 days.
How were Waverley Pharma’s earnings last quarter?
Waverley Pharma released its earnings results on Aug 21, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Waverley Pharma overvalued?
According to Wall Street analysts Waverley Pharma’s price is currently Overvalued.
Does Waverley Pharma pay dividends?
Waverley Pharma does not currently pay dividends.
What is Waverley Pharma’s EPS estimate?
Waverley Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Waverley Pharma have?
Waverley Pharma has 54,000,000 shares outstanding.
What happened to Waverley Pharma’s price movement after its last earnings report?
Waverley Pharma reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Waverley Pharma?
Currently, no hedge funds are holding shares in TSE:WAVE
Company Description
Waverley Pharma
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide. It is also developing WAV-101 and WAV-102 products for the treatment of cancer. Geographically, it derives revenue from the United Kingdom.
Technical Analysis
NanoSphere Health Sciences Inc
―
Biocure Technology Inc
―
Albert Labs International
―
Vaxil Bio
―
WPD Pharmaceuticals
―